Matches in Wikidata for { <http://www.wikidata.org/entity/Q63808328> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63808328 description "clinical trial" @default.
- Q63808328 description "ensayu clínicu" @default.
- Q63808328 description "klinisch onderzoek" @default.
- Q63808328 description "клінічне випробування" @default.
- Q63808328 name "Safety and Pharmacokinetics of ODM-209" @default.
- Q63808328 type Item @default.
- Q63808328 label "Safety and Pharmacokinetics of ODM-209" @default.
- Q63808328 prefLabel "Safety and Pharmacokinetics of ODM-209" @default.
- Q63808328 P1132 Q63808328-9BF4BE9A-12BE-4BB4-A48B-DE55B0371469 @default.
- Q63808328 P1476 Q63808328-077A9151-9C75-4EEF-B49F-A784AA379A10 @default.
- Q63808328 P17 Q63808328-4B21453E-447C-408F-9F70-410AE8D76476 @default.
- Q63808328 P17 Q63808328-57DDBE8A-EDE2-42AF-A172-39D931CDAF79 @default.
- Q63808328 P17 Q63808328-F4673FFB-7E12-45BE-8175-0FD21555A119 @default.
- Q63808328 P1813 Q63808328-486957FC-1FD2-49B7-AE32-3AC2538E4622 @default.
- Q63808328 P2899 Q63808328-942225B9-2709-4052-8DC9-E1955995F29B @default.
- Q63808328 P3098 Q63808328-56073376-FD23-481B-810E-CD8C0B00DA78 @default.
- Q63808328 P31 Q63808328-37F79EDF-5FBD-4C7C-8079-C917E78F2BA1 @default.
- Q63808328 P580 Q63808328-E3085826-660A-4DAB-B10F-4BADF5FA756A @default.
- Q63808328 P582 Q63808328-232C61A5-9CAF-46D3-BCAC-1CE91F7AFC1E @default.
- Q63808328 P6099 Q63808328-3CEF1348-7194-4274-A98D-CB88113CA996 @default.
- Q63808328 P6099 Q63808328-52847D2F-2D26-4AFE-9E6F-32B3DAF7FF3A @default.
- Q63808328 P6153 Q63808328-27695435-6413-458D-AE07-C8FB70DFE5A4 @default.
- Q63808328 P6153 Q63808328-B4FE6B87-BFF6-4934-BF3C-7C192C860D3D @default.
- Q63808328 P6153 Q63808328-FAE326D1-C36A-4A35-B3BD-9CEDAD56A420 @default.
- Q63808328 P8363 Q63808328-2BDC8207-06AF-4FAC-A7C0-5CB89E7BCB4E @default.
- Q63808328 P1132 "+256" @default.
- Q63808328 P1476 "Safety and Pharmacokinetics of ODM-209 in Patients With Metastatic Castration-resistant Prostate Cancer or Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer" @default.
- Q63808328 P17 Q142 @default.
- Q63808328 P17 Q33 @default.
- Q63808328 P17 Q35 @default.
- Q63808328 P1813 "STESIDES" @default.
- Q63808328 P2899 "+18" @default.
- Q63808328 P3098 "NCT03878823" @default.
- Q63808328 P31 Q30612 @default.
- Q63808328 P580 "2019-03-01T00:00:00Z" @default.
- Q63808328 P582 "2023-01-01T00:00:00Z" @default.
- Q63808328 P6099 Q42824440 @default.
- Q63808328 P6099 Q5452194 @default.
- Q63808328 P6153 Q266227 @default.
- Q63808328 P6153 Q28695 @default.
- Q63808328 P6153 Q56403399 @default.
- Q63808328 P8363 Q78089383 @default.